Gerald Friedland

Director of the AIDS Program, Yale New Haven Hospital and Professor of Medicine and Epidemiology and Public Health, Yale School of Medicine

Gerald Friedland is the Director of the AIDS Program at Yale New Haven Hospital and Professor of Medicine and Epidemiology and Public Health at Yale School of Medicine. He is a former member of the Governing Council of the International AIDS Society, National Advisory Council, National Institute on Drug Abuse and Advisory Council, Office of AIDS Research, and currently serves on the WHO HIV/TB Working Group and as the Chairman of the Board of Directors of the Aaron Diamond AIDS Research Center in New York City.

Dr. Friedland has been directly involved in the development of comprehensive HIV care programs since the beginning of the HIV epidemic in 1981. He has developed and directed large-scale clinical and epidemiologic studies among vulnerable populations with and at risk for HIV disease. His group presented the first convincing evidence of lack of transmission of HIV by close personal contact, and defined the predictors of HIV transmission and natural history of HIV disease among injection drug users as well as the risk of reactivation of tuberculosis among those co-infected with M.Tb and HIV. More recently, Dr. Friedland has worked on clinical trials of antiretroviral therapies. His research also has focused on studies at the interface of biology, clinical care, and behavior, including adherence to HIV therapies and the integration of prevention strategies and clinical care, notably in the development and testing of interventions to reduce HIV transmission risk among HIV+ persons in clinical care.

Dr. Friedland is also actively involved in international research aimed at providing access to antiretroviral therapy in resource-limited settings. The work now now focuses on the diagnosis, treatment, and reduction of transmission of multiple drug resistant (MDR) and extensively resistant tuberculosis (XDR TB) in HIV co-infected patients. Dr. Friedland directs and participates in several research projects addressing these issues in rural and urban South Africa, supported by charitable research foundations and the NIH. He is a Visiting Professor at the Nelson. R Mandela School of Medicine of the University of KwaZulu Natal in Durban, South Africa and the Mailman School of Public Health of Columbia University.